Gene · 5731
Papers2,455
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,455
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Stromal heterogeneity may explain increased incidence of metaplastic breast cancer in women of African descent. | Nat Commun | 2023 | 37709737 | PubTator, text mining | PubMed |
| Trinity of inflammation, innate immune cells and cross-talk of signalling pathways in tumour microenvironment. | Front Pharmacol | 2023 | 37680708 | PubTator, text mining | PubMed |
| Alternative promoters and splicing create multiple functionally distinct isoforms of oestrogen receptor alpha in breast cancer and healthy tissues. | Cancer Med | 2023 | 37676103 | PubTator, text mining | PubMed |
| CAR virus receptor mediates erythroid differentiation and migration and is downregulated in MDS. | Leukemia | 2023 | 37673973 | PubTator, text mining | PubMed |
| Synthesis and clinical application of new drugs approved by FDA in 2022. | Mol Biomed | 2023 | 37661221 | PubTator, text mining | PubMed |
| Gene Immunotherapy of Colon Carcinoma with IL-2 and IL-12 Using Gene Electrotransfer. | Int J Mol Sci | 2023 | 37629081 | PubTator, text mining | PubMed |
| Expression of Prostaglandin Genes and β-Catenin in Whole Blood as Potential Markers of Muscle Degeneration. | Int J Mol Sci | 2023 | 37629065 | PubTator, text mining | PubMed |
| Ultrasonography and Sonoelastography Characteristics of Benign vs. Malignant Mesenteric Lymph Nodes in Cats: An Update. | Animals (Basel) | 2023 | 37627454 | PubTator, text mining | PubMed |
| Uterine collision tumor (PEComa and endometrioid carcinoma) in a tuberous sclerosis patient: a case report. | Front Oncol | 2023 | 37621679 | PubTator, text mining | PubMed |
| BRCA1 promoter methylation & its immunohistochemical correlation in sporadic breast cancer. | Indian J Med Res | 2023 | 37602586 | PubTator, text mining | PubMed |
| The severity of NEC is ameliorated by prostaglandin E2 through regulating intestinal microcirculation. | Sci Rep | 2023 | 37591866 | PubTator, text mining | PubMed |
| Normal and dysregulated crosstalk between iron metabolism and erythropoiesis. | Elife | 2023 | 37578340 | PubTator, text mining | PubMed |
| Rice-produced classical swine fever virus glycoprotein E2 with herringbone-dimer design to enhance immune responses. | Plant Biotechnol J | 2023 | 37572354 | PubTator, text mining | PubMed |
| Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors. | Cancer Res Commun | 2023 | 37559947 | PubTator, text mining | PubMed |
The Impact of Acute Mild Normobaric Hypoxia and a Single Bout of Exercise to Volitional Exhaustion on Cognitive Performance in Endurance and Strength-Trained Athletes: The role of BDNF, EP-1, Catecholamines and Lactate. | J Hum Kinet | 2023 | 37559758 | PubTator, text mining | PubMed |
| The immune microenvironment characterisation and dynamics in hormone receptor-positive breast cancer before and after neoadjuvant endocrine therapy. | Cancer Med | 2023 | 37553911 | PubTator, text mining | PubMed |
| EP1 activation inhibits doxorubicin-cardiomyocyte ferroptosis via Nrf2. | Redox Biol | 2023 | 37531930 | PubTator, text mining | PubMed |
| Prorelaxant E-type Prostanoid Receptors Functionally Partition to Different Procontractile Receptors in Airway Smooth Muscle. | Am J Respir Cell Mol Biol | 2023 | 37523713 | PubTator, text mining | PubMed |
| Inhibitory effects of NSAID-conjugated SN-38 on the viability of A549 Non-small cell lung cancer cells. | Biochem Biophys Rep | 2023 | 37521373 | PubTator, text mining | PubMed |
Results of Induction of Labor with Prostaglandins E1 and E2 (The RIPE Study): A Real-World Data Analysis of Obstetrical Effectiveness and Clinical Outcomes of Pharmacological Induction of Labor with Vaginal Inserts. | Pharmaceuticals (Basel) | 2023 | 37513894 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5731/papers?page=8